King Luther Capital Management Corp Amgen Inc Transaction History

King Luther Capital Management Corp

$21.9 Billion
Q2 2024

A detailed history of King Luther Capital Management Corp transactions in Amgen Inc stock. As of the latest transaction made, King Luther Capital Management Corp holds 511,380 shares of AMGN stock, worth $165 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares

511,380

Previous 511,919 0.11%

Holding current value

$165 Million

Previous $146 Million 9.78%

% of portfolio

0.73%

Previous 0.66%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $141,622 - $172,108	-539 Reduced 0.11%	511,380 $160 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $3.7 Million - $4.46 Million	-13,750 Reduced 2.62%	511,919 $146 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $630,556 - $711,342	2,466 Added 0.47%	525,669 $151 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $125,067 - $155,275	572 Added 0.11%	523,203 $141 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $3.21 Million - $3.8 Million	-14,990 Reduced 2.79%	522,631 $116 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $492,222 - $599,936	-2,180 Reduced 0.4%	537,621 $130 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $401,489 - $510,140	-1,753 Reduced 0.32%	539,801 $142 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $933,080 - $1.05 Million	-4,157 Reduced 0.76%	541,554 $122 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $530,171 - $589,988	-2,298 Reduced 0.42%	545,711 $133 Million
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $119,282 - $131,958	-544 Reduced 0.1%	548,009 $133 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $910,472 - $1.04 Million	-4,578 Reduced 0.83%	548,553 $123 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $3.84 Million - $4.49 Million	-18,068 Reduced 3.16%	553,131 $118 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $2.57 Million - $2.86 Million	-11,022 Reduced 1.89%	571,199 $139 Million
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $1.5 Million - $1.75 Million	-6,755 Reduced 1.15%	582,221 $145 Million
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $2.24 Million - $2.67 Million	-10,352 Reduced 1.73%	588,976 $135 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $769,652 - $855,916	-3,280 Reduced 0.54%	599,328 $152 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $234,404 - $287,646	1,185 Added 0.2%	602,608 $142 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $2.03 Million - $2.69 Million	-11,128 Reduced 1.82%	601,423 $122 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $333,388 - $428,518	-1,762 Reduced 0.29%	612,551 $148 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $2.26 Million - $2.71 Million	-12,999 Reduced 2.07%	614,313 $119 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $662,299 - $776,363	-3,973 Reduced 0.63%	627,312 $116 Million
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $2.35 Million - $2.65 Million	13,017 Added 2.11%	631,285 $120 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $1.96 Million - $2.29 Million	10,976 Added 1.81%	618,268 $120 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $248,288 - $279,912	-1,340 Reduced 0.22%	607,292 $126 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $833,903 - $936,653	-5,022 Reduced 0.82%	608,632 $112 Million
Q1 2018 May 08, 2018	BUY	$169.43 - $198.0 $2.07 Million - $2.41 Million	12,195 Added 2.03%	613,654 $105 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $3,375 - $3,771	20 Added 0.0%	601,459 $105 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $101 Million - $115 Million	601,439	601,439 $112 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.

Account

King Luther Capital Management Corp Amgen Inc Transaction History